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Abstract
Background: Legionella pneumophila is a common cause of community-acquired pneumonia. Central nervous
system dysfunction is common, and diagnosis in the absence of pulmonary symptoms can be challenging. Here we
describe an atypical clinical presentation of Legionella infection in a patient with HIV who was found to have an
unusual neuroradiologic lesion that further served to obscure the diagnosis. This is the first such description in a
patient with Legionellosis and HIV coinfection.
Case presentation: A 43 year-old HIV positive man presented to our hospital with dysarthria, fevers, headache,
and altered mental status. Initial work-up revealed pneumonia and a lesion of the splenium of the corpus callosum
on magnetic resonance imaging. He was subsequently diagnosed with Legionella pneumonia and treated with
complete symptom resolution.
Conclusions: Neurologic abnormalities are frequent in Legionellosis, but the diagnosis may be difficult in the
absence of overt respiratory symptoms and in the presence of HIV coinfection. A high index of suspicion and
early initiation of empiric antibiotics is imperative since early treatment may help prevent long-term sequelae.
Neuroimaging abnormalities, though rare, can help the physician narrow down the diagnosis and avoid
unnecessary invasive testing. Future studies should aim to elucidate the as yet unknown role of neuroimaging in
the diagnoses and prognostication of Legionellosis, as well as the interaction between Legionella infection and HIV.
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Background
Legionella pneumophila is now recognized as a major
cause of both community-acquired pneumonia [1] and
nosocomial pneumonia [2], accounting for between 2
and 15% of pneumonias requiring hospitalization [3].
The central nervous system (CNS) is involved in up
to 50% of patients [4], and permanent sequalae are
among the most feared complications of infection. While
relatively straightforward to treat, diagnosis of Legion-
ellosis can be obscured by multiorgan system involve-
ment, particularly in the absence of obvious respiratory
symptomatology. There is rarely evidence of CNS infec-
tion by neuroimaging, cerebrospinal fluid (CSF) analysis,
or pathologic evaluation [5-8], which further confuses
diagnosis in atypical cases. In the case study reported
below, we describe the challenge of diagnosing Legion-
ella in a patient with HIV who presented with neuro-
logic deficits and a hyperintense lesion of the splenium
of the corpus callosum (SCC) on magnetic resonance
imaging (MRI). To the best of our knowledge, this is the
first such description of these radiologic findings in a pa-
tient with Legionellosis and HIV coinfection. This report
highlights the pitfalls, challenges, and importance of
diagnosing Legionella infection when neurologic symp-
toms predominate. * Correspondence: Nathaniel.Robbins@ucsf.edu
1Department of Neurology, University of California, 505 Parnassus Ave.
M-798, San Francisco, CA 94137, USA
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Initial presentation
A 43 year-old male was referred to the Emergency
Department (ED) of our hospital after his workplace col-
leagues noted increasingly strange behavior for three
days. The patient arrived complaining of generalized
fatigue, lethargy, fevers, severe band-like headache,
slurred speech, and increasing confusion. Though it was
felt that the patient’s history was not completely reliable
secondary to confusion, he was able to deny throat pain,
chest pain, diarrhea, abdominal pain, recent sick con-
tacts, or recent travel. Review of systems was limited
secondary to altered mental status, but he did admit to
mild dry cough.
Though initially denying immune compromise in the
ED, the patient later disclosed he was HIV+. He could
not recall his CD4 count but stated that his last viral
load was undetectable. Past medical history was signifi-
cant for hypertension and hypercholesterolemia. Out-
patient medications included Atripla, spironolactone,
and gemfibrozil. He had a history of unprotected anal
sex with men but denied new partners. He had no recent
contact with animals. He smoked a pack of cigarettes
per day but did not drink or use drugs.
In the ED, the patient’s temperature was 103.9°F
(39.9°C). Heart rate was 121 beats per minute, and re-
spiratory rate was 30 breaths per minute. Oxygen satur-
ation was 94% on room air. Blood pressure was 142/90.
The patient appeared unwell. He was somnolent but
easily aroused. Pertinent findings on general physical
exam included a supple neck and decreased breath
sounds diffusely. On neurologic exam, he was noted to
be dysarthric. He had general slowness of thought and
processing. He was slightly confused, though he was
oriented and able to name the days of the week for-
wards and backwards if given sufficient time.
Initial laboratory evaluation was notable for a white
blood cell (WBC) count of 10.1 × 10
3 cells/mm
3, [lab
reference range 4.0–10.8], hemoglobin of 15.7 g/dL [lab
range 14.0–18.0], platelet count of 135 × 10
3/mm
3
[lab range 150–350]. Automated differential showed
87.5% segmented cells (lab range 30-85%), 9.3% lympho-
cytes (lab range 15-55%), 2.4% monocytes (lab range
0-10%), 0.8% eosinophils (lab range 0-5%), and 0% baso-
phils. No manual differential was performed. A basic
metabolic panel showed serum sodium of 134 mmol/L
[lab range 137–145], serum potassium of 4.2 mmol/L
(lab range 3.5-5.1), serum chloride of 100 mmol/L (lab
range 98–107), and CO2 of 19 mmol/L [lab range 22.0–
30.0]. Blood urea nitrogen, serum creatinine, and serum
glucose were elevated at 33 mg/dL [lab range 9–20],
1.8 mg/dL [lab range 0.7–1.3] and 159 mg/dL [lab range
70–99], respectively. C-reactive protein (CRP) was high
at 581 mg/dL [lab range 0–10]. Liver function studies
showed an albumin level of 4.4 g/dL (lab range 3.5-5.0),
total protein of 7.6 g/dL (lab range 6.3-8.2), total biliru-
bin of 0.7 mg/dL (lab range 0.2-1.3), direct bilirubin of
0.5 mg/dL (lab range 0–0.3), alkaline phosphatase of
62 U/L (lab range 38–126), alanine aminotransferase
(ALT) of 49 U/L (lab range 13–69), and aspartate amino-
transferase (AST) of 89 U/L (lab range 15–46). Urinalysis
showed 2+ albumin, 3+ blood, trace WBC esterase, nega-
tive nitrite, 5–10 WBC, 0–5 red blood cells (RBC), 5–10
epithelial cells, 5–10 hyaline casts, 3+ amorphous cells,
and 1+ mucous. A non-contrast computed tomography
(CT) scan of the head did not reveal any abnormalities.
Nasopharyngeal influenza assay was negative.
Due to the combination of altered mental status, head-
ache, and fever, a lumbar puncture was performed. The
results demonstrated an elevated cerebrospinal fluid
(CSF) glucose of 97 mg/dL [normal 40–70], CSF protein
of 37 mg/dL [normal 12–60], and normal cell count and
gram stain. Blood cultures were sent.
A chest x-ray was done and was read as a left
hilar mass extending down towards the left lower lobe
(see Figure 1). A chest CT was obtained to better
characterize the hilar mass (see Figure 2). This chest CT
demonstrated a left lower lobe consolidation with air
bronchograms suggesting a diagnosis of pneumonia.
Based upon the aforementioned findings, the patient was
started on azithromycin and ceftriaxone for community-
acquired pneumonia, as well as empiric acyclovir for
herpes encephalitis.
Given the findings of dysarthria and altered mental
status in an HIV+individual with unknown CD4+ count,
a brain MRI was obtained. No contrast was administered
secondary to acute renal injury. The diffusion-weighted
Figure 1 Chest x-ray demonstrating a left hilar mass.
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abnormal restricted diffusion and swelling of the sple-
nium of the corpus callosum without other significant ab-
normalities. Abnormal T2-weighted signal in the SCC
can be seen in Figure 4. These MRI findings in an HIV+
individual raised concern for CNS opportunistic infec-
tion. However, since the patient was hemodynamically
stable, was on antiretroviral therapy, and had a negative
lumbar puncture, it was decided to treat the pneumonia
initially and closely monitor the patient’s mental status.
Hospital course
Over the first two to three days of hospitalization, the
patient continued to have high fevers, confusion, and
dysarthria. His laboratory markers improved on antibio-
tics. His serum CRP trended down from 581 mg/L at
admission to 200 mg/L on day three. After day three
the patient began to demonstrate significant clinical
improvement. The patient’s admission CD4+ count
returned on day three at 156 cells/mm
3, and an HIV
viral load came back on day four at <20 copies/mL. On
day four, urine antigens for Streptococcus pneumoniae
and Legionella pneumophila serogroup 1 were sent. By
day five the patient’s neurologic symptoms had resolved,
as had his acute renal insufficiency. This same day his
Legionella pneumophila urinary antigen returned positive.
On hospital day six a repeat MRI was obtained to
monitor radiologic progression of the SCC lesion. This
repeat study showed partial interval clearing of the pre-
viously noted abnormalities: restricted diffusion, abnor-
mal increased flair, and abnormal T2 signally in the
SCC. On hospital day seven the patient was discharged
home on oral azithromycin. He had no residual deficits.
Initial CSF viral studies including herpes simplex virus 1
and 2, varicella, cytomegalovirus, enterovirus, and JC
virus all returned negative, as did the syphilis, hepatitis
B, and hepatitis C serologies. Sputum for acid fast bacilli
Figure 2 Chest CT demonstrating left-sided pneumonia.
Figure 3 Axial MRI brain without contrast demonstrating
restricted diffusion of the SCC on DWI.
Figure 4 Axial T2-weighted MRI without contrast demonstrating
focal hyperintensity of the SCC.
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IgG titers sent on day four later came back at 1:64.
Discussion
Legionella and the CNS
Here we present an HIV + patient who presented with
confusion, dysarthria, and fever, and was subsequently
found with a lesion of the SCC on MRI before being
diagnosed with Legionella pneumonia. “Legionnaire’s
disease” was first described in the late 1970s in a series
of articles outlining an emerging respiratory epidemic
[9-14]. While relatively straightforward to treat, the
challenge in Legionellosis is to make a diagnosis early
and to initiate appropriate treatment, as delaying therapy
is associated with increased mortality [15]. Legionella
is effectively treated with macrolides, quinolones, or
tetracyclines [1].
CNS involvement is a feared and relatively common
sequela of Legionellosis, as has been described in detail
[7,16-23]. Neurologic problems range from peripheral
neuropathy [24] to myositis [25] to isolated nerve palsies
[26] to acute disseminated encephalomyelitis (ADEM)
[27-29]. Altered mental status and headache were the
most frequent neurologic symptoms in one series [7],
occurring in 29.6% and 28.7% of patients, respectively.
Cerebellar signs are less common in Legionellosis, but
also well-described [6,30]. As mentioned previously, it is
rare to observe evidence of infection by neuroimaging,
cerebrospinal fluid (CSF) analysis, or pathologic evalu-
ation [5-8]. Electroencephalogram (EEG) may show
diffuse slowing or may be normal [6]. In severe cases
with neurologic involvement, focal deficits may not
fully resolve even with adequate antibiotic coverage
[6,7]. Fortunately this patient was treated upon presen-
tation with adequate empiric antibiotics and made a
complete recovery.
One prominent feature of this case was the unusual
radiologic findings that accompanied the patient’s en-
cephalopathy. Though radiologic or pathologic confirm-
ation of Legionellosis is reported to be rare, one
previously recorded case study on Legionellosis with
cerebellar involvement also describes an isolated enhan-
cing lesion of the SCC on MRI [4]. This nonspecific
reversible lesion [31] has been described previously in a
host of infectious [32-35] and non-infectious [34] causes,
including antiepileptic drug-withdrawal, high-altitude
cerebral edema, and metabolic disorders [35]. The fre-
quency of this lesion is likely underreported, since most
patients who present with altered mental status do not
receive an MRI. The cellular pathophysiologic cause of
an isolated SCC is as yet unknown, though various
theories have been posited [34,35]. In the neuropsychi-
atric and neuroanatomical literature, the SCC is thought
to mediate interhemispheric transfer of information, but
its precise role in human cognition remains to be
defined [36]. We cannot state with certainty what role
the SCC abnormality played in the presentation of our
patient, as the causes and correlates of this abnormality
are not well-studied to this point.
Splenial lesions on MRI, if symptomatic, are most
commonly associated with delirium, ataxia, recent seiz-
ure, hemispheric disconnection syndrome, dysarthria,
increased tone, or headache. These nonspecific findings
do not easily localize anatomically [34]. Because of this
apparent contradiction, Morgan et al. postulated that
additional areas of the brain may be affected even if MRI
cannot detect involvement [4]. Working on this hypoth-
esis, Imai and colleagues found evidence of diffuse cere-
bellar and frontal lobe hypoperfusion on single photon
emission CT in a patient with Legionella pneumonia
who presented similarly to the patient described in the
case study: respiratory symptoms, confusion, dysarthria,
and an isolated hyperintense reversible SCC lesion on
MRI diffusion-weighted imaging (DWI) [37]. It remains
to be seen what significance these radiologic findings
hold for the diagnosis and treatment of the Legionella
or the other entities listed above, but clearly more
research is needed in order to understand the utility of
this radiologic abnormality in diagnosing and prognosti-
cating encephalopathy.
Legionella and HIV
Coinfection with HIV confused timely diagnosis in this
patient with Legionellosis. Legionella pneumonia has
been observed but not well-studied in HIV + individuals
[38,39], and it is unknown if HIV infection predisposes
an individual to more severe Legionellosis or CNS
involvement. This patient’s CD4+ count was reduced,
but Legionellosis is known to cause lymphopenia in the
acute setting [40], so the role of HIV-induced lymphope-
nia as a risk-factor for Legionella infection in this
context is unclear. At the least, HIV seropositivity and
the predominance of neurologic symptomatology in this
case distracted the clinicians from making a prompt
diagnosis, highlighting the importance of early empiric
antibiotic therapy.
Conclusions
We describe an unusual case of Legionella pneumonia in
a patient with HIV infection who presented with altered
mental status, dysarthria, and neuroimaging abnormal-
ities that cleared with clinical improvement. In this case,
appropriate antibiotic therapy was started immediately
upon presentation, even though the diagnosis of Legio-
nellosis was not made until urinary antigens came back
four days later. The patient did indeed make a complete
recovery, and we presume early antibiotic therapy helped
in this convalescence to some extent.
Robbins et al. BMC Infectious Diseases 2012, 12:225 Page 4 of 6
http://www.biomedcentral.com/1471-2334/12/225This patient underwent brain MRI because he pre-
sented acutely ill with confusion and dysarthria in the
setting of HIV infection without an obvious diagnosis.
MRI revealed an isolated defect of the SCC. The signifi-
cance of this lesion and the utility of advanced imaging
techniques in encephalopathy in general and Legionello-
sis specifically is not known, since to date no prospec-
tive studies have evaluated the utility of either MRI
or SPECT in the work-up of altered mental status or
other neurologic signs in Legionellosis. Though cost is
currently a significant barrier, these imaging modalities
may be useful to assess prognosis, determine optimal
treatment length, and possibly even diagnose Legionello-
sis when CNS symptoms predominate. Further research
in this area is required. Regardless, clinicians need to be
aware of this nonspecific finding so as to avoid unneces-
sary invasive procedures in the setting of encephalopathy.
The other challenging aspect of this patient’s presenta-
tion was his coinfection with HIV. Given the limited re-
search into the relationship between Legionella and HIV,
additional investigation is warranted in order to better
understand the immunologic interplay.
In summary, clinicians should consider Legionella
infection in patients who present with altered mental
status or neurologic symptoms, even when few respira-
tory symptoms are reported. Failure to send Legionella
urinary antigens on presentation in this case led to a
delay in diagnosis, though fortunately this patient was
initially placed on adequate empiric therapy anyway. In
the absence of overt respiratory symptoms, clinicians
need to maintain a high index of suspicion as early ther-
apy may help prevent permanent neurologic sequelae.
Consent
Written informed consent was obtained from the patient
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review by the Series Editor of this journal.
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